Skip to main content
European Commission logo print header

Phenotypes and genes linked to insulin resistance and risk for type 2 diabetes

Objective

Type 2 diabetes is a major global health problem, which is undergoing an epidemic development. Effective intervention and treatment require the understanding of the genetic and molecular mechanisms involved. The objectives of this proposal are to identify at least 800 healthy first-degree relatives to Type 2 diabetic subjects. And a similar control group lacking known genetic predisposition. Extensive and novel technology will be used to characterize clinical subphenotypes. Adipose and muscle biopsies will be obtained for analyses of gene expression using the novel cDNA array technology. Differentially expressed cDNAs will be identified and cloned and biological functions of novel proteins identified. Transgenic/knock-out animals will be generated to identify in vivo functions. In parallel, focused research will be performed aimed at identifying candidate genes, including intracellular signalling molecules and nuclear receptor transcription factors.

Call for proposal

Data not available

Coordinator

GOETEBORG UNIVERSITY
EU contribution
No data
Address
Sahlgrenska University Hospital - Groena Straket,
413 45 GOETEBORG
Sweden

See on map

Total cost
No data

Participants (7)